HGHayley B. Gershengorn

Hayley B. Gershengorn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hayley B. Gershengorn has a total of 315 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quantifying Nurse and Physician Clinical Performance for Mechanically Ventilated Patients

    by Christopher F. Chesley, Yingying Lu, Rachel Kohn, Hayley B. Gershengorn, Kelly C. Vranas, Catherine L. Hough, Olga Yakusheva, Deena Kelly Costa, Deanna J. Marriott, David A. Asch, et al.

    Objective: Expanding on previous research applying value‐added modeling to clinician performance measurement, we quantified simultaneous nurse and physician performance among mechanically ventilated patients. Study Setting and Design: In a retrospective cohort spanning five academic hospitals, we used multiple linear regression to determine relationships between nurse and physician assignments and changes in patient illness severity (Laboratory‐based Acute Physiology Score) during intensive care unit (ICU) admission. Individual clinician performance was derived from regression coefficients. Collective clinician contribution to disease severity variance was assessed by comparing the coefficient of determination across clinician‐only and joint‐clinician models. Consistency of clinician performance estimates was cross‐validated using random 1:1 partitions of the patient population using Pearson's correlation. Data Sources and Analytic Sample: Electronic health record data were extracted from mechanically ventilated patients at study ICUs between 2018 and 2022. Principal Findings: Among 17,082 clinical encounters, 215 physicians, and 1719 nurses, nurse and physician assignments improved model fit. Together, they attributed 7% of variability in disease severity trajectory; separately, nurse assignments accounted for greater variance than physician assignments (6% vs. 4%, respectively). Cross‐partition clinician performance was moderately correlated ( r = 0.31 [nurses] , r = 0.4 [physicians], p < 0.001 for both comparisons). Conclusions: Individual nurse and physician care independently contribute to disease severity trajectory among mechanically ventilated patients.

  • Critical illness outcomes of hospitalized pregnant women following a Texas abortion ban

    by Catherine Chen, Deepshikha C Ashana, Kevin Callison, Courtney Baker, Ralph Nicholas Burns, Jing Cao, Li Yuan, Hayley B Gershengorn

    Importance: In September 2021, Texas Senate Bill 8 (SB8) banned abortion after embryonic cardiac activity. Objective: To estimate the association of SB8 with critical illness rates. Design: Interrupted time series (ITS). Setting: Hospitals in Texas. Participants: Retrospective cohort of pregnant women between 10 and 54 years of age hospitalized between January 2018 and March 2024. A subgroup of patients with high-risk features, defined as age 34 years or ≥ 1 chronic illness. Measurements: The primary outcome was critical illness, defined as sepsis or mechanical ventilation (MV). Secondary outcomes included sepsis, MV, and infection without organ dysfunction. ITS results are reported as the immediate step change and the sustained slope change (ie, difference in trend line slopes following vs without SB8). Results: In the full cohort (n = 2 344 135), SB8 was not associated with rates of critical illness, sepsis, MV, or infection in adjusted analyses. Following SB8, significantly more hospitalized pregnant patients had high-risk features (slope change per quarter per 1000 hospitalizations: 0.92 [0.08, 1.77]). In the high-risk subgroup (n = 497 144), SB8 was significantly associated with sustained increases in critical illness, sepsis, and infection (slope changes per quarter per 1000 hospitalizations: 0.17 [0.02, 0.33], 0.15 [0.02, 0.28], 1.60 [1.02, 2.17], respectively), but not MV (slope change per quarter per 1000 hospitalizations: 0.05 [−0.03, 0.13]). No significant step changes were observed. Conclusion: Following SB8, hospitalized pregnant women with high-risk features experienced significant increases in rates of critical illness, sepsis, and infection. These results may inform infection prevention programs and critical illness training in abortion-restrictive states.


  • Use and dosing of ketamine infusions in mechanically ventilated patients: a population-based cohort study of ICUs in Alberta Canada

    by Andrea D. Hill, Allan Walkey, Lisa Burry, David N. Juurlink, Nicholas A. Bosch, Bijan Teja, Henry T. Stelfox, Hayley B. Gershengorn, Theodore J. Iwashyna, Hannah Wunsch

  • Vasoactive regimens and outcomes in patients with septic shock: an observational cohort study

    by Sabreen Bhuiya, Bijan Teja, Anica C Law, Hayley Gershengorn, Theodore J Iwashyna, Emily Vail, Allan J Walkey, Hannah Wunsch, Nicholas A Bosch

  • Validation of a charge-based algorithm for identifying days receiving invasive mechanical ventilation

    by Zhan Shi, Nicholas A Bosch, Eric J Heckman, Hayley B Gershengorn, Divya A Shankar, Anica C Law


  • Open Access

    Association of a Platelet Shortage with process and clinical outcomes

    by Hayley B. Gershengorn, Yanyun Wu, Andrea Carlotto, Samira Patel, Christopher M. Mallow, Dipen J. Parekh, Kymberlee J. Manni, Tanira Ferreira

    Background: Little is known about how platelet shortages impact patient care and outcomes. In the summer of 2024, a ransomware event substantially impacted blood product processing capacity in South Florida, creating a natural experiment to evaluate such a shortage. Study Design and Methods: We conducted a retrospective study of platelet test results—categorized as <10,000/μL (universal transfusion recommendation), 10,000–49,000/μL (equivocal transfusion indication), and ≥50,000/μL (transfusion rarely indicated)—from adults hospitalized at the University of Miami Hospital and Clinics during (July 29–August 4) versus pre‐ (July 1–July 28) or post‐ (August 5–September 1) shortage. Results: We included 26,457 platelet results—46.3% pre‐, 11.3% during, 42.3% post‐shortage—from 3605 hospitalizations. Platelet counts of 10,000–49,000/μL in the pre‐ (odds ratio [95% confidence interval]: 3.05 [1.43, 6.51]) and post‐ (2.89 [1.27, 6.60]) periods were more often followed by transfusions within 6 h than during the shortage. No difference was observed following platelet counts <10,000/μL or ≥50,000/μL. We found no statistically significant difference in hospital mortality or hemorrhage across periods. However, during the shortage mortality was numerically higher (20.0% vs. pre: 15.2%, post: 18.3%) and hemorrhage was lower (0.0% vs. pre: 19.0%, post: 18.3%) for hospitalizations with nadir platelet counts of 10,000–49,000/μL. Discussion: Shortage conditions were associated with fewer platelet transfusions following counts of 10,000–49,000/μL without significant patient harm. These findings suggest that, with sufficient resources, it is possible to change practice quickly and that guideline‐concordant care for platelet transfusions may reduce waste while maintaining quality.

  • Patient Race and Preferred Language Influence the Use of Physical Restraints on Nonintubated Intensive Care Unit Patients

    by Samuel K. McGowan, Hayley B. Gershengorn, Andrew Sudler, Edie Espejo, John Boscardin, Lingsheng Li, Alexander K. Smith, Deepshikha C. Ashana, Karthik Raghunathan, Shannen Kim, et al.

    Rationale: Physical limb restraints are commonly used in intensive care units (ICUs) to protect patients and staff but are associated with increased morbidity and disparities in care, particularly in intubated patients. Whether disparities in restraint use persist for nonintubated patients remains less clear. Objectives: We sought to identify whether patient race, ethnicity, and preferred language are associated with restraint use in nonintubated patients across multiple ICUs in a large U.S. hospital system. Methods: We performed a retrospective cohort study using electronic health record data across five ICUs within the University of California, San Francisco, from 2013 to 2022. We included adults who were 18 years of age and older. We excluded patients who received mechanical ventilation during their ICU stay. Our primary independent variables were primary language, race, and ethnicity. The outcome of interest was restraint use, defined as at least one restraint order placed during the patient’s ICU stay. We modeled any restraint use using a multivariable logistic regression adjusted for sociodemographic and clinical covariates and explored interactions of our primary exposures using sensitivity analyses and Wald testing. Results: Across 22,259 unique ICU admissions, we identified 11,676 nonintubated patients. Of these, 2,411 (20%) received an order for physical restraints. In a multivariable regression model, compared with English, Chinese (all dialects) (odds ratio [OR], 1.57; 95% confidence interval [CI], 1.31–1.87) and a language other than Chinese, English, or Spanish (OR, 1.60; 95% CI, 1.36–1.89) were associated with increased use of restraints. Patients identifying as Black or African American were also more likely to be restrained at least once during the encounter (OR, 1.51; 95% CI, 1.27–1.79) compared with non-Hispanic White patients. Conclusions: Patients preferring Chinese or any language other than English or Spanish and those who identify as Black are more likely to be restrained in the ICU when not intubated. Interventions to minimize the use of unnecessary physical restraints could improve an inequity known to be associated with downstream harms.


  • Inotrope selection in mixed cardiogenic shock with sepsis: a comparative analysis between milrinone and dobutamine

    by Boyangzi Li, Hayley B Gershengorn, Emily A Vail, Hannah Wunsch, Allan J Walkey, Anica C Law, Darae Ko, Nir Ayalon, Christopher M Kearney, Nicholas A Bosch

    Rationale: Despite increasing recognition of mixed cardiogenic shock—particularly in patients with concomitant sepsis—there remains limited guidance on optimal inotropic selection, and the comparative effectiveness of different inotropes in this population is unclear. Objective: To examine the association between inotrope selection and in-hospital outcomes, including all-cause mortality, among patients with cardiogenic shock and sepsis. Methods: Using the PINC AI enhanced-claims database (2016-2022), we identified patients with cardiogenic shock and sepsis using International Classification of Diseases, Tenth Revision codes (ICD-10) that were present on hospital admission and a pharmacy charge code for dobutamine or milrinone within 2 days of hospitalization. The primary outcome was all-cause hospital mortality. Secondary outcomes included inotrope duration, in-hospital length of stay, atrial arrhythmia, initiation of renal replacement therapy, use of mechanical circulatory support devices, and heart transplantation. We used greedy nearest neighbor matching on the propensity score (dobutamine vs milrinone) followed by g-computation to estimate effects of inotrope selection on outcomes. We examined heterogeneity of treatment effect in patients with renal disease, congestive heart failure, pulmonary circulatory diseases, and on epinephrine prior to inotrope initiation. Results: Out of 10 447 included patients, 74.4% received dobutamine and 25.6% received milrinone. Postmatching characteristics between the milrinone and dobutamine groups were similar (all standardized mean differences <0.1). The primary outcome all-cause mortality was similar between the postmatched milrinone and dobutamine groups (41.6% vs 42.7%; risk difference, -1.4% [95% CI, -3.7% to 1.5%]; P = .40). Patients initiated on milrinone (vs dobutamine) had longer inotrope durations (5.1 vs 3.5 days; mean difference, 1.7 [95% CI, 1.4-1.9] days; P < .001), longer in-hospital length of stay (10.0 vs 9.1 days; mean difference, 0.9 [95% CI, 0.4-1.3] days; P < .001), and more usage of anti-arrhythmic agents (56.0% vs 44.5%; mean difference, 11.5% [95% CI, 8.9%-14.1%]; P < .001). We did not observe any heterogeneity of treatment effect for all-cause mortality based on the preexisting conditions of interest. Conclusions: Using a large, multicenter cohort, we identified no differences in all-cause mortality between dobutamine and milrinone among patients with concurrent cardiogenic shock and sepsis overall. However, secondary outcomes favored dobutamine.